Cargando…

Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet

Background: The high consumption of fat and sugar contributes to the development of obesity and co-morbidities, such as diabetes, and cardiovascular and kidney diseases. Different strategies have been used to prevent these diseases associated with obesity, such as changes in eating habits and/or the...

Descripción completa

Detalles Bibliográficos
Autores principales: Francisqueti, Fabiane Valentini, Minatel, Igor Otávio, Ferron, Artur Junio Togneri, Bazan, Silméia Garcia Zanati, Silva, Vanessa dos Santos, Garcia, Jéssica Leite, de Campos, Dijon Henrique Salomé, Ferreira, Ana Lúcia, Moreto, Fernando, Cicogna, Antonio Carlos, Corrêa, Camila Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748750/
https://www.ncbi.nlm.nih.gov/pubmed/29186059
http://dx.doi.org/10.3390/nu9121299
_version_ 1783289464311775232
author Francisqueti, Fabiane Valentini
Minatel, Igor Otávio
Ferron, Artur Junio Togneri
Bazan, Silméia Garcia Zanati
Silva, Vanessa dos Santos
Garcia, Jéssica Leite
de Campos, Dijon Henrique Salomé
Ferreira, Ana Lúcia
Moreto, Fernando
Cicogna, Antonio Carlos
Corrêa, Camila Renata
author_facet Francisqueti, Fabiane Valentini
Minatel, Igor Otávio
Ferron, Artur Junio Togneri
Bazan, Silméia Garcia Zanati
Silva, Vanessa dos Santos
Garcia, Jéssica Leite
de Campos, Dijon Henrique Salomé
Ferreira, Ana Lúcia
Moreto, Fernando
Cicogna, Antonio Carlos
Corrêa, Camila Renata
author_sort Francisqueti, Fabiane Valentini
collection PubMed
description Background: The high consumption of fat and sugar contributes to the development of obesity and co-morbidities, such as diabetes, and cardiovascular and kidney diseases. Different strategies have been used to prevent these diseases associated with obesity, such as changes in eating habits and/or the addition of dietary components with anti-inflammatory and anti-oxidant properties, such as gamma-oryzanol (γOz) present mainly in bran layers and rice germ. Methods: Animals were randomly divided into four experimental groups and fed ad libitum for 20 weeks with control diet (C, n = 8), control diet + γOz (C + γOz, n = 8), high-sugar and high-fat diet (HSF, n = 8), and high-sugar and high-fat diet + γOz (HSF + γOz, n = 8). HSF groups also received water + sucrose (25%). The dose of γOz was added to diets to reach 0.5% of final concentration (w/w). Evaluation in animals included food and caloric intake, body weight, plasma glucose, insulin, triglycerides, uric acid, HOMA-IR, glomerular filtration rate, protein/creatinine ratio, systolic blood pressure, and Doppler echocardiographic. Results: Animals that consumed the HSF diet had weight gain compared to group C, increased insulin, HOMA, glucose and triglycerides, there were also atrial and ventricular structural alterations, deterioration of systolic and diastolic function, decreased glomerular filtration rate, and proteinuria. Gamma-oryzanol is significantly protective against effects on body weight, hypertriglyceridemia, renal damage, and against structural and functional alteration of the heart. Conclusion: Gamma-oryzanol shows potential as a therapeutic to prevent Cardiorenal Metabolic Syndrome.
format Online
Article
Text
id pubmed-5748750
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57487502018-01-07 Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet Francisqueti, Fabiane Valentini Minatel, Igor Otávio Ferron, Artur Junio Togneri Bazan, Silméia Garcia Zanati Silva, Vanessa dos Santos Garcia, Jéssica Leite de Campos, Dijon Henrique Salomé Ferreira, Ana Lúcia Moreto, Fernando Cicogna, Antonio Carlos Corrêa, Camila Renata Nutrients Article Background: The high consumption of fat and sugar contributes to the development of obesity and co-morbidities, such as diabetes, and cardiovascular and kidney diseases. Different strategies have been used to prevent these diseases associated with obesity, such as changes in eating habits and/or the addition of dietary components with anti-inflammatory and anti-oxidant properties, such as gamma-oryzanol (γOz) present mainly in bran layers and rice germ. Methods: Animals were randomly divided into four experimental groups and fed ad libitum for 20 weeks with control diet (C, n = 8), control diet + γOz (C + γOz, n = 8), high-sugar and high-fat diet (HSF, n = 8), and high-sugar and high-fat diet + γOz (HSF + γOz, n = 8). HSF groups also received water + sucrose (25%). The dose of γOz was added to diets to reach 0.5% of final concentration (w/w). Evaluation in animals included food and caloric intake, body weight, plasma glucose, insulin, triglycerides, uric acid, HOMA-IR, glomerular filtration rate, protein/creatinine ratio, systolic blood pressure, and Doppler echocardiographic. Results: Animals that consumed the HSF diet had weight gain compared to group C, increased insulin, HOMA, glucose and triglycerides, there were also atrial and ventricular structural alterations, deterioration of systolic and diastolic function, decreased glomerular filtration rate, and proteinuria. Gamma-oryzanol is significantly protective against effects on body weight, hypertriglyceridemia, renal damage, and against structural and functional alteration of the heart. Conclusion: Gamma-oryzanol shows potential as a therapeutic to prevent Cardiorenal Metabolic Syndrome. MDPI 2017-11-29 /pmc/articles/PMC5748750/ /pubmed/29186059 http://dx.doi.org/10.3390/nu9121299 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Francisqueti, Fabiane Valentini
Minatel, Igor Otávio
Ferron, Artur Junio Togneri
Bazan, Silméia Garcia Zanati
Silva, Vanessa dos Santos
Garcia, Jéssica Leite
de Campos, Dijon Henrique Salomé
Ferreira, Ana Lúcia
Moreto, Fernando
Cicogna, Antonio Carlos
Corrêa, Camila Renata
Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title_full Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title_fullStr Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title_full_unstemmed Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title_short Effect of Gamma-Oryzanol as Therapeutic Agent to Prevent Cardiorenal Metabolic Syndrome in Animals Submitted to High Sugar-Fat Diet
title_sort effect of gamma-oryzanol as therapeutic agent to prevent cardiorenal metabolic syndrome in animals submitted to high sugar-fat diet
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748750/
https://www.ncbi.nlm.nih.gov/pubmed/29186059
http://dx.doi.org/10.3390/nu9121299
work_keys_str_mv AT francisquetifabianevalentini effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT minateligorotavio effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT ferronarturjuniotogneri effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT bazansilmeiagarciazanati effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT silvavanessadossantos effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT garciajessicaleite effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT decamposdijonhenriquesalome effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT ferreiraanalucia effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT moretofernando effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT cicognaantoniocarlos effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet
AT correacamilarenata effectofgammaoryzanolastherapeuticagenttopreventcardiorenalmetabolicsyndromeinanimalssubmittedtohighsugarfatdiet